|In addition to providing patient care and family support based on the most current approaches to diagnosis, treatment and long-term management, CHEO's IBD Centre conducts basic laboratory research and clincial studies in pediatrics. Our research is conducted both at CHEO and collaboratively with other related institutes and centres.
Message from the CHEO IBD Centre Director
Canada has amongst the highest rates of IBD in the world.
IBD is a chronic lifelong gastrointestinal disease for which the cause is unknown.
The rate of IBD in children has increased by 50% since 1994.
These statements are the driving force behind what motivates the CHEO IBD Centre Research Team. Our own larger multi-investigator studies are being funded through a number of sources including Genome Canada together with the Ontario Government, the Canadian Institutes of Health Research, and C.H.I.L.D. Foundation. Other CHEO based studies are being funded though the CHEO Research Institute, The American College of Gastroenterology and local donors such as parents and local businesses. We are also involved in a number of studies of national and international scope that we hope will enable greater understanding of predictors of outcomes, determinants of health, epidemiology of the disease, growth and bone health issues and begin in the important initiation of standards of care for IBD in children. Our growing collaborations with University of Ottawa, Institute for Clinical Evaluative Sciences (ICES), national and international collaborative Pediatric IBD research groups including PROKIIDS Network as well as CHILD-CIHR Canadian Children IBD Network are important to us to enhance our commitment to expansion of research. However, bringing these discoveries through community awareness, trust, and support of research locally within Ottawa at CHEO are also tremendously important aspects of what we strive to accomplish.
“We work on greater understanding of Crohn's disease and ulcerative colitis, how better to care and treat these diseases and to determine how to have the best outcomes. Fostering the development of clinical and research expertise both locally and beyond is an important avenue to gain access to new health care practices. At the CHEO IBD Centre, we strongly believe in collaborative efforts and strive to be strong partners in North American and international IBD studies and initiatives. Our hope is that this will allow for a more rapid gain in knowledge, earlier implementation of the best new practices and improvements in pediatric IBD care which is a consistent goal and expectation of our research activities.”
Dr. David Mack – Director, CHEO IBD Centre